EU regulator warns of insufficient data on inhaled steroids to treat Covid-19
The European Medicines Agency said although its Covid-19 taskforce had not found any safety risks so far for the corticosteroids, it could not exclude the possibility of harm in patients who have normal oxygen levels
Photo: REUTERS
Europe's medicines regulator said on Thursday there was insufficient evidence to support use of inhaled corticosteroids to treat patients with Covid-19, but said there was enough data at present to continue usage of dexamethasone.
The European Medicines Agency said although its Covid-19 taskforce had not found any safety risks so far for the corticosteroids, it could not exclude the possibility of harm in patients who have normal oxygen levels.
